Similar articles

• The use of maggot therapy in the treatment of a malignant foot wound.

  Sealby N. Sealby N. Br J Community Nurs. 2004 Mar;9(3):S16-9. doi: 10.12968/bjcn.2004.9.Sup1.12501. Br J Community Nurs. 2004. PMID: 15029003
• Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers.

  Tantawi TI, Gohar YM, Kotb MM, Beshara FM, El-Naggar MM. Tantawi TI, et al. J Wound Care. 2007 Oct;16(9):379-83. doi: 10.12968/jowc.2007.16.9.27868. J Wound Care. 2007. PMID: 17987750
• Principles of management: the diabetic foot.

  Wieman TJ. Wieman TJ. Am J Surg. 2005 Aug;190(2):295-9. doi: 10.1016/j.amjsurg.2005.05.030. Am J Surg. 2005. PMID: 16023449 Review.
• The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients.

  Gilead L, Mumcuoglu KY, Ingber A. Gilead L, et al. J Wound Care. 2012 Feb;21(2):78, 80, 82-85. doi: 10.12968/jowc.2012.21.2.78. J Wound Care. 2012. PMID: 22584527
• The value of debridement and Vacuum-Assisted Closure (V.A.C.) Therapy in diabetic foot ulcers.

  Eneroth M, van Houtum WH. Eneroth M, et al. Diabetes Metab Res Rev. 2008 May-Jun;24 Suppl 1:S76-80. doi: 10.1002/dmrr.852. Diabetes Metab Res Rev. 2008. PMID: 18393328 Review.